Copyright © 2001 by the European Society of Cardiology.
Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality
a Division of Cardiology, Conegliano General Hospital, Padua, Italy
b Division of Internal Medicine, Adria General Hospital, Padua, Italy
c Division of Cardiology, Bassano del Grappa General Hospital, Padua, Italy
d Clinica Medica 4, University of Padova, Padua, Italy
revised December 22, 2000; accepted January 2, 2001
Abstract
Aims Urinary albumin excretion increases during acute myocardial infarction but little is known on the prognostic significance and the pathophysiological mechanisms of microalbuminuria in this clinical setting. The primary aim of the study was to examine whether urinary albumin excretion has predictive power for 1-year mortality after acute myocardial infarction. A secondary objective was to gain insight into the pathophysiological mechanisms of increased urinary albumin in myocardial infarction.
Methods and Results This is a prospective cohort study conducted in three coronary care units (Northeast Italy). Four hundred and thirty-two unselected, consecutively enrolled patients with acute myocardial infarction (66·3± 12·3 years of age) were studied. The incidence of mortality was related to the baseline urinary albumin:creatinine ratio. The best cut-off for total mortality approximated to 50mg.g–1on the first day after myocardial infarction, 30mg.g–1on the third day, and to 20mg.g–1on the seventh day. At multivariable Cox analysis, the albumin:creatinine ratio was the strongest among several independent predictors of mortality (adjusted relative risks: 3·6 (95% CI, 2·1–6·2) on the first day, 4·9 (95% CI, 2·9–8·2) on the third day and 4·0 (95% CI, 2·3–6·8) on the seventh day). Independent determinants of urinary albumin were plasma aldosterone on the first day, and inflammatory markers on the third and seventh days.
Conclusion Urinary albumin assessed in the first week after acute myocardial infarction is a strong prognostic marker for 1-year mortality.
Key Words: acute myocardial infarction, microalbuminuria, albumin:creatinine ratio, aldosterone, inflammatory markers, prognosis
f1 Correspondence: Professor Paolo Palatini, Clinica Medica 4, Via Giustiniani, 2, 35128 Padova, Italy.
References
- N Engl J Med. 1983;309:331–336[Abstract]
- Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ. 1993;307:349–353
[Abstract/Free Full Text] - Nicod P, Gilpin E, Dittrich H. Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol. 1988;61:1165–1171[CrossRef][Web of Science][Medline]
- Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med. 1990;322:743–753[Web of Science][Medline]
- Gosling P, Hughes EA, Reynolds JP, Fox JP. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J. 1991;12:508–513
[Abstract/Free Full Text] - Taskiran M, Feldt-Rasmussen B, Jensen GB, Jensen JS. Urinary albumin excretion in hospitalized patients with acute myocardial infarction. Prevalence of microalbuminuria and correlation to left ventricle wall thickness. Scand Cardiovasc J. 1998;32:163–166[CrossRef][Web of Science][Medline]
- Berton G, Citro T, Palmieri R, Petucco S, De Toni R, Palatini P. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation. 1997;96:3338–3345
[Abstract/Free Full Text] - Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356–360[Abstract]
- Kuusisto J, Mykkänen L, Pyörälä, Markku L. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation. 1995;91:831–837
[Abstract/Free Full Text] - Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988;2:530–533[Web of Science][Medline]
- Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457–464[CrossRef][Web of Science][Medline]
- Bradows RG, Nichols D, Shaker G, Kubasik NP. Evaluation of a new radioimmunoassay for urinary albumin. Diabetes Care. 1986;9:189–193[Abstract]
- Jensen JS, Clausen P, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant. 1997;12:6–9
[Free Full Text] - Altman DG. Modelling survival, the Cox regression model. Practical statistics for medical research. London: Chapman & Hall; 1992. p. 387–94
- Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation. 1996;94:1291–1297
[Abstract/Free Full Text] - Touboul P, Andre-Fouet X, Leizorovicz A. Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde. Eur Heart J. 1997;18:99–107
[Abstract/Free Full Text] - Pierard LA, Albert A, Chapelle JP, Carlier J, Kulbertus HE. Relative prognostic value of clinical, biochemical, echocardiographic and haemodynamic variables in predicting inhospital and one-year cardiac mortality after acute myocardial infarction. Eur Heart J. 1989;10:24–31
[Abstract/Free Full Text] - Foy SG, Crozier IG, Richards AM. Neurohumoral changes after acute myocardial infarction. Relationships withhaemodynamic indices and effects of ACE inhibition. Eur Heart J. 1995;16:770–778
[Abstract/Free Full Text] - Omland T, Bonarjee VVS, Lie RT, Caidahl K. Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction. Am J Cardiol. 1995;76:230–235[CrossRef][Web of Science][Medline]
- Richards AM, Nicholls MG, Yandle TG. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 1998;97:1921–1929
[Abstract/Free Full Text] - Anzai T, Yoshikawa T, Shiraki H. C-Reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 1997;96:778–784
[Abstract/Free Full Text] - Rouleau JL, Packer M, Moye L. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol. 1994;24:583–591[Abstract]
- Mak KH, Moliterno DJ, Granger CB. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:171–179[Abstract]
- Eiskjaer H, Bagger JP, Mogensen CE, Schmitz A, Pedersen EB. Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition. Scand J Lab Invest. 1992;52:193–199
- Ellekilde G, von Eyben FE, Holm J, Hemmingsen L. Above-normal urinary excretion of albumin and retinol-binding protein in patients with acute myocardial infarction. Clin Chem. 1993;39:2350–2351[Web of Science][Medline]
- Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J. 1996;17:1345–1349
[Abstract/Free Full Text] - Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore JM, Goldberg RJ. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol. 1996;78:945–948[CrossRef][Web of Science][Medline]
- Maseri A. Inflammation, atherosclerosis, and ischemic events. Exploring the hidden side of the moon. N Engl J Med. 1997;336:1014–1016
[Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Montalescot, H. Drexler, R. Gallo, T. Pearson, M. Thoenes, and D. L. Bhatt Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study Eur. Heart J., November 2, 2009; 30(22): 2733 - 2741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Danziger Importance of Low-Grade Albuminuria Mayo Clin. Proc., July 1, 2008; 83(7): 806 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rodriguez-Yanez, M. Castellanos, M. Blanco, M. Millan, F. Nombela, T. Sobrino, I. Lizasoain, R. Leira, J. Serena, A. Davalos, et al. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology, October 10, 2006; 67(7): 1172 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jose, C. Tomson, H. Skali, J. Rouleau, E. Braunwald, J. M. Arnold, T. Cuddy, B. Sussex, V. Bernstein, M. Pfeffer, et al. Influence of Proteinuria on Cardiovascular Risk and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1725 - 1727. [Full Text] [PDF]
|
|
|
|
|
|
G. Berton and P. Palatini Measurement of albuminuria during acute myocardial infarction and its relation with prognosis Eur. Heart J., June 2, 2005; 26(12): 1242 - 1242. [Full Text] [PDF]
|
|
|
|
|
|
C. Kragelund, O. Snorgaard, L. Kober, and C. Torp-Pedersen Measurement of albuminuria during acute myocardial infarction and its relation with prognosis: reply Eur. Heart J., June 2, 2005; 26(12): 1242 - 1243. [Full Text] [PDF]
|
|
|
|
 |
|
 R. P.E. van Dokkum, W. B.A. Eijkelkamp, A. C.A. Kluppel, R. H. Henning, H. van Goor, M. Citgez, W. A.K.M. Windt, D. J. van Veldhuisen, P. A. de Graeff, and D. de Zeeuw Myocardial Infarction Enhances Progressive Renal Damage in an Experimental Model for Cardio-Renal Interaction J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3103 - 3110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kragelund, O. Snorgaard, L. Kober, B. Bengtsson, M. Ottesen, S. Hojberg, C. Olesen, J.-J. Kjaergaard, J. Carlsen, C. Torp-Petersen, et al. Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients Eur. Heart J., November 1, 2004; 25(21): 1891 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Olijhoek, Y. van der Graaf, J.-D. Banga, A. Algra, T. J. Rabelink, F. L. J. Visseren, and for the SMART Study Group The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm Eur. Heart J., February 2, 2004; 25(4): 342 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Yuyun, K.-T. Khaw, R. Luben, A. Welch, S. Bingham, N. E. Day, and N. J. Wareham A Prospective Study of Microalbuminuria and Incident Coronary Heart Disease and Its Prognostic Significance in a British Population: The EPIC-Norfolk Study Am. J. Epidemiol., February 1, 2004; 159(3): 284 - 293. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||